نتایج جستجو برای: tp53 protein

تعداد نتایج: 1240012  

Background: Molecular marker based cancer diagnosis gaining more attention in the current genomics era. So, Hspb1 and Tp53 gene characterization and their mRNA expression might be helpful in diagnosis andprognosis ofcat mammary adenocarcinoma. It will also add informationin comparative cancer genetics and genomics. Objectives: Eight tumors of Siamese cats were analyzed to ascertain germ-line an...

Gastric cancer (GC) is one of the leading causes of cancer mortality, worldwide. Molecular understanding of GC’s different subtypes is still dismal and it is necessary to develop new subtype-specific diagnostic and therapeutic approaches. Therefore developing comprehensive research in this area is demanding to have a deeper insight into molecular processes, underlying these subtypes. In this st...

2012
Tanielly Cristina Raiol Silva Mariana Ferreira Leal Danielle Queiroz Calcagno Carolina Rosal Teixeira de Souza André Salim Khayat Ney Pereira Carneiro dos Santos Raquel Carvalho Montenegro Silvia Helena Barem Rabenhorst Mayara Quaresma Nascimento Paulo Pimentel Assumpção Marília de Arruda Cardoso Smith Rommel Rodríguez Burbano

BACKGROUND Gastric cancer is a serious public health problem in Northern Brazil and in the world due to its high incidence and mortality. Despite the severity of the disease, more research is needed to better understand the molecular events involved in this intestinal-type gastric carcinogenesis process. Since precancerous lesions precede intestinal-type gastric cancer, here, we evaluated the h...

Journal: :The international journal of biochemistry & cell biology 2011
Claudia B Levy Ana C Stumbo Ana P D Ano Bom Elisabeth A Portari Yraima Cordeiro Jerson L Silva Claudia V De Moura-Gallo

P53 is one of the most important tumor suppressor proteins in human cancers. Mutations in the TP53 gene are common features of malignant tumors and normally correlate to a more aggressive disease. In breast cancer, these gene alterations are present in approximately 20% of cases and are characteristically of missense type. In the present work we describe TP53 mutations in breast cancer biopsies...

2012
Gabriel S. Macedo Leonardo Lisbôa da Motta Juliana Giacomazzi Cristina B. O. Netto Vanusa Manfredini Camila S.Vanzin Carmen Regla Vargas Pierre Hainaut Fábio Klamt Patricia Ashton-Prolla

Germline mutations in TP53 are the underlying defect of Li-Fraumeni Syndrome (LFS) and Li-Fraumeni-like (LFL) Syndrome, autosomal dominant disorders characterized by predisposition to multiple early onset cancers. In Brazil, a variant form of LFS/LFL is commonly detected because of the high prevalence of a founder mutation at codon 337 in TP53 (p.R337H). The p53 protein exerts multiple roles in...

2009
A. Mitra C. Jameson Y. Barbachano N. Sodha Z. Kote-Jarai A. Javed E. Bancroft A. Fletcher Christopher S. Foster C. Cooper S. Peock D. Easton R. Eeles

We have shown that prostate cancer occurring in men with germline BRCA1 and BRCA2 mutations is more aggressive. In an attempt to identify an associated immunohistochemical phenotype, we have studied TP53 immunostaining in prostate cancers in mutation carriers versus prostate cancers occurring in a control group of men. There was a significantly higher expression of TP53 protein in prostate canc...

Journal: :Cancer research 2009
Jonathan R Brody Tomas Hucl Christina L Costantino James R Eshleman Eike Gallmeier Heng Zhu Michiel S van der Heijden Jordan M Winter Agnieszka K Wikiewicz Charles J Yeo Scott E Kern

The major determinants of 5-flurouracil (5-FU) response would seem, based on accumulated literature, to be thymidylate synthase (TYMS, TS) expression levels, TS gene modifications, and TP53 status. We tested 5-FU sensitivity in yeast and human cancer cell models in which TS or TP53 alleles and expression were varied. Polymorphic TS tandem repeat status, TS expression levels reported, TS intrage...

2017
Eric J. Devor Jesus Gonzalez-Bosquet Akshaya Warrier Henry D. Reyes Nonye V. Ibik Brandon M. Schickling Andreea Newtson Michael J. Goodheart Kimberly K. Leslie

Placenta-specific protein 1 (PLAC1) expression is co-opted in numerous human cancers. As a consequence of PLAC1 expression, tumor cells exhibit enhanced proliferation and invasiveness. This characteristic is associated with increased aggressiveness and worse patient outcomes. Recently, the presence of the tumor suppressor p53 was shown in vitro to inhibit PLAC1 transcription by compromising the...

2017
Guangzhi Zhu Xiwen Liao Chuangye Han Xiaoguang Liu Long Yu Wei Qin Sicong Lu Hao Su Zhiwei Chen Zhengtao Liu Yu Liang Jianlu Huang Tingdong Yu Chengkun Yang Ketuan Huang Liming Shang Xinping Ye Lequn Li Xue Qin Kaiyin Xiao Minhao Peng Tao Peng

Aldehyde dehydrogenase 1 family member L1 (ALDH1L1) is downregulated in hepatocellular carcinoma (HCC) tumors, and its decreased expression is associated with the poor prognosis of HCC patients. We, therefore, evaluated the effect of single nucleotide polymorphisms (SNPs) of ALDH1L1, and its mRNA expression on the survival of hepatitis B virus (HBV)‑related HCC patients and the association with...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Marlon Lindenbergh-van der Plas Ruud H Brakenhoff Dirk J Kuik Marijke Buijze Elisabeth Bloemena Peter J F Snijders C René Leemans Boudewijn J M Braakhuis

PURPOSE TP53 is a key gene in cellular homeostasis and is frequently mutated in head and neck squamous cell carcinoma (HNSCC). There is a variety of TP53 mutations, each with its own biological and clinical implication. Aim of the study was to assess the prognostic significance of TP53 mutations in HNSCCs and to identify the most relevant mutation. EXPERIMENTAL DESIGN TP53 mutation status was...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید